文献速递神经康复

机器人强化卒中治疗优化康复(RESTORE):一项试点研究

Robot enhanced stroke therapy optimizes rehabilitation (RESTORE): a pilot study.
PubMed 文献 · J Neuroeng Rehabil · 2021-01-21

该试点研究为亚急性卒中患者设计9项Kinarm外骨骼机器人上肢治疗任务,将19例受试者匹配分为机器人治疗组(N=9,每日1小时、共10天,加标准治疗)和对照组(N=10,仅标准治疗)。结果显示干预可行且不良事件极少,机器人治疗组FMA UE、ARAT、FIM及视觉引导 Reach 任务均显著改善,而对照组仅FIM和Arm Position Match改善。

要点

  • 亚急性卒中患者每日1小时、共10天附加机器人治疗可行且不良事件极少
  • 机器人治疗组FMA UE、ARAT、FIM及视觉引导 Reach 任务均显著改善
  • 对照组仅FIM和Arm Position Match在同期改善,组间基线无显著差异

核心结论

  • Kinarm机器人治疗任务有潜力改善亚急性卒中患者结局,但需更大样本研究量化获益。

研究设计与样本

  • 试点研究,亚急性卒中受试者以匹配分组方式分为机器人治疗组(N=9)和对照组(N=10)。

主要发现

  • 参与者为亚急性卒中(39.8天 post-stroke),干预期间不良事件极少,附加1小时机器人治疗可行。
  • 两组基线的临床和机器人评分无显著差异。
  • 机器人治疗组完成干预后FMA UE、ARAT、FIM和Visually Guided Reaching评分显著改善。
  • 对照组在相同时间内仅FIM和Arm Position Match改善。

关键数值与推荐

  • 机器人治疗组每日完成1小时机器人治疗、共10天,并附加标准治疗;对照组仅接受标准治疗。
  • 临床评估包括FMA UE、ARAT和FIM;机器人评估包括Visually Guided Reaching和Arm Position Match等。
  • 采用配对样本t检验比较机器人治疗前后评分及干预前后临床和机器人评估。

临床怎么用

  • 亚急性卒中患者可考虑在标准治疗基础上附加每日1小时、共10天的Kinarm机器人上肢治疗。
  • 该方案可行性好、不良事件极少,但获益需更大样本研究验证。

局限性

  • 为试点研究,样本量小(机器人组N=9、对照组N=10),未来需更大队列量化获益。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Robotic rehabilitation after stroke provides the potential to increase and carefully control dosage of therapy. Only a small number of studies, however, have examined robotic therapy in the first few weeks post-stroke. In this study we designed robotic upper extremity therapy tasks for the bilateral Kinarm Exoskeleton Lab and piloted them in individuals with subacute stroke. Pilot testing was focused mainly on the feasibility of implementing these new tasks, although we recorded a number of standardized outcome measures before and after training. METHODS: Our team developed 9 robotic therapy tasks to incorporate feedback, intensity, challenge, and subject engagement as well as addressing both unimanual and bimanual arm activities. Subacute stroke participants were assigned to a robotic therapy (N = 9) or control group (N = 10) in a matched-group manner. The robotic therapy group completed 1-h of robotic therapy per day for 10 days in addition to standard therapy. The control group participated only in standard of care therapy. Clinical and robotic assessments were completed prior to and following the intervention. Clinical assessments included the Fugl-Meyer Assessment of Upper Extremity (FMA UE), Action Research Arm Test (ARAT) and Functional Independence Measure (FIM). Robotic assessments of upper limb sensorimotor function included a Visually Guided Reaching task and an Arm Position Matching task, among others. Paired sample t-tests were used to compare initial and final robotic therapy scores as well as pre- and post-clinical and robotic assessments. RESULTS: Participants with subacute stroke (39.8 days post-stroke) completed the pilot study. Minimal adverse events occurred during the intervention and adding 1 h of robotic therapy was feasible. Clinical and robotic scores did not significantly differ between groups at baseline. Scores on the FMA UE, ARAT, FIM, and Visually Guided Reaching improved significantly in the robotic therapy group following completion of the robotic intervention. However, only FIM and Arm Position Match improved over the same time in the control group. CONCLUSIONS: The Kinarm therapy tasks have the potential to improve outcomes in subacute stroke. Future studies are necessary to quantify the benefits of this robot-based therapy in a larger cohort. TRIAL REGISTRATION: ClinicalTrials.gov, NCT04201613, Registered 17 December 2019-Retrospectively Registered, https://clinicaltrials.gov/ct2/show/NCT04201613 .

来源:J Neuroeng Rehabil,查看原文。版权归原作者所有。

引用

  1. Keeling AB, Piitz M, Semrau JA, et al. Robot enhanced stroke therapy optimizes rehabilitation (RESTORE): a pilot study. J Neuroeng Rehabil. 2021. PMID: 33478563. doi:10.1186/s12984-021-00804-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。